Skip to main content
. Author manuscript; available in PMC: 2017 Dec 22.
Published in final edited form as: J Card Fail. 2017 Jun 13;23(10):762–764. doi: 10.1016/j.cardfail.2017.05.018

Fig. 1.

Fig. 1

Hepatitis C viral load (hep C VL) and Model for End-Stage Liver Disease (MELD) score trends in relationship to donor pool size, transplantation date, and treatment with ledipasvir-sofosbuvir. Suitable organs were found shortly after donor pool expansion to include hepatitis C–positive donors. A sustained virologic response was rapidly achieved after ledipasvir-sofosbuvir treatment. OHT, orthotopic heart transplant.